论文部分内容阅读
为评价动脉内灌注化疗药物和免疫制剂对治疗晚期胃肠道肿瘤的临床疗效 ,将 86例不能切除的胃肠道肿瘤随机分成两组 ,A组 4 6例 ,行动脉灌注化疗同时进行免疫治疗 ,B组 4 0例 ,单纯动脉灌注化疗。结果肿瘤治疗有效率 (CR +PR)A组 82 6 % ,B组5 2 5 % ;0 5、1和 2年生存率 ,A组分别为 10 0 %、82 6 %和 5 6 5 % ,B组分别为 10 0 %、6 5 %和 4 2 5 %。表明动脉内灌注化疗药物和免疫制剂治疗能有效提高晚期胃道肿瘤的治疗效果
To evaluate the clinical efficacy of intra-arterial chemotherapy and immunotherapy in the treatment of advanced gastrointestinal cancer, 86 unresectable gastrointestinal cancers were randomly divided into two groups. A group of 46 patients received intra-arterial chemotherapy and immunotherapy , B group 40 cases, simple arterial infusion chemotherapy. Results The effective rates of tumor treatment (CR + PR) were 82.6% in group A and 52.5% in group B, respectively. The 0, 5, 1 and 2 year survival rates were 100%, 82.6% and 56.5% Group B were 100%, 65% and 425% respectively. The results showed that intra-arterial infusion of chemotherapy drugs and immunotherapy can effectively improve the therapeutic effect of advanced gastric cancer